These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21379418)

  • 1. Intradermal delivery of vaccines: potential benefits and current challenges.
    Hickling JK; Jones KR; Friede M; Zehrung D; Chen D; Kristensen D
    Bull World Health Organ; 2011 Mar; 89(3):221-6. PubMed ID: 21379418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal delivery for vaccine dose sparing: overview of current issues.
    Zehrung D; Jarrahian C; Wales A
    Vaccine; 2013 Jul; 31(34):3392-5. PubMed ID: 23176978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Devices for intradermal vaccination.
    Kis EE; Winter G; Myschik J
    Vaccine; 2012 Jan; 30(3):523-38. PubMed ID: 22100637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
    Lambert PH; Laurent PE
    Vaccine; 2008 Jun; 26(26):3197-208. PubMed ID: 18486285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
    Chen MC; Lai KY; Ling MH; Lin CW
    Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice.
    Nicolas JF; Guy B
    Expert Rev Vaccines; 2008 Oct; 7(8):1201-14. PubMed ID: 18844594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine.
    Tozuka M; Oka T; Jounai N; Egawa G; Ishii KJ; Kabashima K; Takeshita F
    J Dermatol Sci; 2016 Apr; 82(1):38-45. PubMed ID: 26674124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass vaccination: solutions in the skin.
    Glenn GM; Kenney RT
    Curr Top Microbiol Immunol; 2006; 304():247-68. PubMed ID: 16989274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routing dependent immune responses after experimental R848-adjuvated vaccination.
    van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
    Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous vaccination: antigen delivery into or onto the skin.
    Weniger BG; Glenn GM
    Vaccine; 2013 Jul; 31(34):3389-91. PubMed ID: 23684830
    [No Abstract]   [Full Text] [Related]  

  • 11. Microneedle-based vaccines.
    Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
    Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems.
    Puri N; Weyand EH; Abdel-Rahman SM; Sinko PJ
    Vaccine; 2000 May; 18(23):2600-12. PubMed ID: 10775794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous and intradermal vaccination.
    Combadiere B; Liard C
    Hum Vaccin; 2011 Aug; 7(8):811-27. PubMed ID: 21817854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: A systematic review.
    Schnyder JL; Garcia Garrido HM; De Pijper CA; Daams JG; Stijnis C; Goorhuis A; Grobusch MP
    Travel Med Infect Dis; 2021; 41():102007. PubMed ID: 33711425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance and usability evaluation of novel intradermal injection device Immucise™ and reanalysis of intradermal administration trials of influenza vaccine for the elderly.
    Shimizu S; Tanaka R; Itoh E; Maekawa-Matsuura M; Iwase Y
    Vaccine; 2022 Feb; 40(6):873-879. PubMed ID: 35031147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of efficacy and safety of intradermal delivery of vaccines through microneedle(s) in human beings: a protocol for a systematic review.
    Bajwa IK; Kaur N; Dsouza JM; Mathew JL
    Syst Rev; 2022 Aug; 11(1):170. PubMed ID: 35964062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children.
    Ploin D; Schwarzenbach F; Dubray C; Nicolas JF; Goujon C; Trong MD; Laurent PE
    Vaccine; 2011 Oct; 29(46):8438-42. PubMed ID: 21821081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery systems for intradermal vaccination.
    Kim YC; Jarrahian C; Zehrung D; Mitragotri S; Prausnitz MR
    Curr Top Microbiol Immunol; 2012; 351():77-112. PubMed ID: 21472533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency ultrasound to assess skin thickness in healthy adults.
    Van Mulder TJ; de Koeijer M; Theeten H; Willems D; Van Damme P; Demolder M; De Meyer G; Beyers KC; Vankerckhoven V
    Vaccine; 2017 Mar; 35(14):1810-1815. PubMed ID: 27496276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.